Prostate Biopsy: Is it Still Relevant Today?
Year: 2025
Type: article
Abstract: Prostate biopsy is considered the gold standard in diagnosing prostate cancer (PCa). However, the field of PCa diagnostics has evolved significantly, with advancements in imaging, biomarker detection and artificial intelligence raising the question of whether a biopsy-free diagnosis is possible. The challenge lies in achieving high sensitivity and specificity without missing clinically significant PCa. Multiple different approaches have been investigated ranging from radiological, urine-based and seminal fluid-based to blood-based. In this review article, we will describe the currently available modalities and various prospects.
Source: Journal of Medical Evidence
Authors: Ritesh Goel, Manav Suryavanshi
Institution: Amrita Vishwa Vidyapeetham
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W4411504605